Showing results (851-860 of 1,007) with videos related to

Sort By:
Pageof 101
Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2016
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodiesRudolf Richter, Caner Süsal, Stefanie Köhler, et al.
Annals of Neurology|July 3, 2003
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET studyAlan L Whone, Ray L Watts, A Jon Stoessl, et al.
Neurology|March 13, 2002
Bilateral human fetal striatal transplantation in Huntington's diseaseR A Hauser, S Furtado, C R Cimino, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 6, 2012
Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptorsJiahui Zhang, Yun-De Xiao, Kristen G Jordan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 4, 2018
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapyClaudia Sommerer, Michael Duerr, Oliver Witzke, et al.
Investigative Ophthalmology & Visual Science|May 26, 2005
Early adult-onset POAG linked to 15q11-13 using ordered subset analysisR Rand Allingham, Janey L Wiggs, Elizabeth R Hauser, et al.
Journal of the American Chemical Society|July 5, 2024
Photon-Modulated Bond Covalency of [Sm(II)(η9-C9H9)2]T Vitova, H Ramanantoanina, B Schacherl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2020
Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behaviorGuorong Li, Heather Schmitt, William M Johnson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's DiseaseAnthony E Lang, Robert A Hauser, Lorraine V Kalia, et al.
The Lancet. Psychiatry|July 3, 2017
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trialKaren E Anderson, David Stamler, Mat D Davis, et al.
Pageof 101